Medline Inc. Class A Common Stock (MDLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has a cash flow conversion efficiency ratio of 0.037x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($715.00 Million) by net assets ($19.08 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medline Inc. Class A Common Stock (MDLN) market capitalisation for the company's overall valuation and market capitalisation.
Medline Inc. Class A Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Medline Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medline Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their cash flow conversion efficiency. Explore MDLN cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MongoDB
NASDAQ:MDB
|
0.069x |
|
BOE Technology Group Co Ltd
SHE:000725
|
0.068x |
|
Nokia Oyj
HE:NOKIA
|
0.030x |
|
Vodafone Group Plc
F:VODJ
|
0.104x |
|
Nestle India Limited
NSE:NESTLEIND
|
0.449x |
|
Extra Space Storage Inc
NYSE:EXR
|
0.034x |
|
Hannover Rück SE
F:HNR1
|
0.128x |
|
China Hongqiao Group Ltd
F:H0Q
|
N/A |
Annual Cash Flow Conversion Efficiency for Medline Inc. Class A Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. View Medline Inc. Class A Common Stock stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.29 Billion | $1.74 Billion | 0.090x | -15.53% |
| 2024-12-31 | $16.52 Billion | $1.77 Billion | 0.107x | +7.86% |
| 2023-12-31 | $16.98 Billion | $1.69 Billion | 0.099x | -- |
About Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more